bupranolol - CISMeF

Preferred Label : bupranolol;

MeSH definition : An adrenergic-beta-2 antagonist that has been used for cardiac arrhythmia, angina pectoris, hypertension, glaucoma, and as an antithrombotic.;

CISMeF synonym : desma brand of bupranolol hydrochloride;

MeSH hyponym : betadrenol; KL-255; KL 255; KL255;

MeSH CAS label : 2-Propanol, 1-(2-chloro-5-methylphenoxy)-3-((1,1-dimethylethyl)amino)-, hydrochloride, ( -)-;

MeSH Related Number : 23284-25-5 (Bupranolol);

Registry Number MeSH : 23284-25-5;

Is substance : O;

UNII : 858YGI5PIT;

InChIKey : HQIRNZOQPUAHHV-UHFFFAOYSA-N;

Details

Origin ID

D002046;

UMLS CUI

C0006403;

ATC code(s)
- bupranolol [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Bupranolol [ICD-11 Extension code]
- Bupranolol [ICHI extension code]
- Bupranolol [SMS substance]
- Bupranolol [NCIt concept]
Pharmacological action(s)
- adrenergic beta-antagonists [MeSH Descriptor]
- anti-arrhythmia agents [MeSH Descriptor]
- antihypertensive agents [MeSH Descriptor]
Record concept(s)
- KL-255 [MeSH concept]
- betadrenol [MeSH concept]
- bupranolol [MeSH concept]
Related MeSH Supplementary Concept(s)
- 2-((1-(2-chloro-5-methylphenoxy)-3-tert-butylamino-2-propoxy)succinyl)-1,3-dipalmitoylglyceroyl [MeSH Supplementary Concept]
- 5-carboxybupranolol [MeSH Supplementary Concept]
- 5-demethylbupranolol [MeSH Supplementary Concept]
- bemetizide, bupranolol, triamterene drug combination [MeSH Supplementary Concept]
- bupranolol, isosorbide dinitrate drug combination [MeSH Supplementary Concept]
- bupranolol, spironolactone drug combination [MeSH Supplementary Concept]
- minotensin [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Bupranolol [ICD-11 Extension code]
- Bupranolol [NCIt concept]
- bupranolol [ATC Code]
Validated automatic mappings to BTNT
- bupranolol [ATC Code]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients